United States Myasthenia Gravis Market and Competitive Landscape Highlights 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "US Myasthenia Gravis Market and Competitive Landscape Highlights - 2016" drug pipelines to their offering.

US Myasthenia Gravis Market and Competitive Landscape Highlights - 2016, provides comprehensive insights into Myasthenia Gravis pipeline products, Myasthenia Gravis epidemiology, Myasthenia Gravis market valuations and forecast, Myasthenia Gravis products sales and competitive landscape in the US.

The research is classified into nine sections - Myasthenia Gravis overview including etiology, pathophysiology, and diagnosis, Myasthenia Gravis treatment options, Myasthenia Gravis pipeline products, Myasthenia Gravis market analysis comprising of Myasthenia Gravis epidemiology, key products marketed for Myasthenia Gravis, market valuations and forecast, products sales and market shares.

Research Scope:

  • Myasthenia Gravis Pipeline: Find out the products in clinical trials for the treatment of Myasthenia Gravis by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products.
  • Myasthenia Gravis Epidemiology: Find out the number of patients diagnosed (prevalence) with Myasthenia Gravis in the US.
  • Myasthenia Gravis Products: Identify key products marketed and prescribed for Myasthenia Gravis in the US, including trade name, molecule name, and company.
  • Myasthenia Gravis Product Sales: Find out the sales revenues of Myasthenia Gravis products, both branded and generics, in the US.
  • Myasthenia Gravis Market Valuations: Find out the market size for Myasthenia Gravis products in 2015 in the US. Find out how the market advanced from 2010 and forecast to 2020.
  • Myasthenia Gravis Products Market Share: Find out the market shares for key Myasthenia Gravis products in the US.

Key Topics Covered:

  1. Disease Overview
  2. Myasthenia Gravis Treatments
  3. Myasthenia Gravis Pipeline
  4. US Myasthenia Gravis Epidemiology
  5. Marketed Drugs for Myasthenia Gravis in US
  6. US Myasthenia Gravis Market Size
  7. US Myasthenia Gravis Products Sales
  8. US Myasthenia Gravis Market Competitive Landscape
  9. US Myasthenia Gravis Market Forecast

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/twb5gg/us_myasthenia.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Immune Disorders Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Immune Disorders Drugs